Encapsulating peritoneal sclerosis in liver transplant recipients: a report of 2 cases.
10.4174/astr.2017.92.3.164
- Author:
Kyo Won LEE
1
;
Chan Woo CHO
;
Nuri LEE
;
Sanghoon LEE
;
Jong Man KIM
;
Gyu Seong CHOI
;
Choon Hyuck David KWON
;
Jae Won JOH
;
Suk Koo LEE
Author Information
1. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jw.joh@samsung.com
- Publication Type:Case Report
- Keywords:
Peritoneal fibrosis;
Liver transplantation;
Intestinal obstruction
- MeSH:
Adrenal Cortex Hormones;
Humans;
Intestinal Obstruction;
Intestine, Small;
Liver Transplantation;
Liver*;
Membranes;
Perfusion;
Peritoneal Fibrosis*;
Recurrence;
Sirolimus;
Tamoxifen;
Transplant Recipients*
- From:Annals of Surgical Treatment and Research
2017;92(3):164-167
- CountryRepublic of Korea
- Language:English
-
Abstract:
Encapsulating peritoneal sclerosis (EPS) is a rare cause of intestinal obstruction by a thick fibrous membrane wrapping around the small intestine. It is a possible complication after liver transplantation (LT) that can be fatal. This report describes 2 cases of EPS after LT that were successfully treated with surgery, corticosteroids, tamoxifen, and mammalian target of rapamycin inhibitor. After treatment in both cases, the patients were able to start oral feeding and have been symptom free for more than 1 year. These cases suggests that for the management of EPS, surgical treatment is mandatory when the patients present with symptoms of intestinal obstruction or if there are findings suggestive of decreased mural perfusion. Surgery should be accompanied with medical treatment to prevent the relapse of EPS.
